You are viewing all posts tagged with "OTC derivatives"

Marcus Cree

vice president, risk solutions, SunGard's capital markets business

3
Apr
2012

Q&A: How will risk management change to support the new OTC derivatives model?

Contributor: Marcus Cree

Last week I participated in a webinar and a Twitterview with DerivSource, covering the changing landscape of risk management in the new OTC derivatives workflow model. It goes without saying that risk is at the center of regulatory reform; the new world of risk management must develop to meet the new requirements and challenges facing the OTC derivatives markets.... read more

Tony Scianna

deputy head of strategy, SunGard’s capital markets business

8
Mar
2012

A shifting focus for OTC derivatives

Contributor: Tony Scianna

This blog post originally appeared on FTF News. In recent years, we have seen many developments in getting the industry to light speed in the front office, but now the focus appears to be shifting to real-time data management and post-trade processing applications, especially in the OTC derivatives space. As the CCP landscape continues to evolve in the midst of unprecedented regulatory reform around the globe, firms now face the daunting task of adapting their post-trade processes to meet their current requirements and to prepare for the future.... read more

Nasser Khodri

managing director, Asia-Pacific, SunGard's capital markets business

29
Feb
2012

TEN trends in electronic trading in Asia for 2012

Contributor: Nasser Khodri

The trading landscape in Asia Pacific is becoming more fragmented and regulated. Competition in Asia Pacific will increase, both among Western peers or within the region, as firms bid to provide the highest quality services to clients without incurring unnecessary costs. ... read more

David Morgan

trading and client connectivity, SunGard’s global trading business

27
Jan
2012

Making sense of MiFID 2

Contributor: David Morgan

Interested parties have now had time to digest the European Commission’s October MiFID 2/MiFIR proposals, and major questions have been raised by a wide range of people. Looking briefly at the main areas of debate: Transparency is clearly the Commission’s central watchword in seeking to protect the interests of retail investors, but the big question is whether overly prescriptive regulation of dark pools may damage the ability of asset management firms to trade optimally on behalf of their (ultimately retail) clients.... read more

Peter Banham

global head of strategy, SunGard's capital markets business

16
Dec
2011

10 trends in OTC derivatives

Contributor: Peter Banham

It is clear that regulatory changes are transforming the OTC derivatives space, from execution to settlement. There are many challenges at play here. As we head into 2012, market participants will need to manage large volumes of data in order to clear and process trades, and we will see new pressures on the cost and the more effective use of capital. In response to this industry transformation, my team and I have identified 10 key trends shaping OTC derivatives today.... read more